Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT ID: NCT06598397

Last Updated: 2025-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-18

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will utilize Multiphase Optimization Strategy (MOST) to optimize a smoking cessation treatment for HIV clinical care by directly targeting patient barriers to quitting and clinical care barriers to reaching and effectively treating a broad heterogeneous population of smokers living with HIV. The four intervention components will be aimed at barriers to quitting among smokers living with HIV and include Motivational Interviewing; Peer Mentoring; Text-messaging; Combination Nicotine Replacement Therapy. These components have shown promise in research but are under-utilized to help smokers living with HIV quit and have not been tested in an optimization trial. This study will also incorporate data to evaluate the fidelity, acceptability and feasibility of the interventions in the HIV clinical care context in order to identify the most cost-effective, sustainable and scalable tobacco treatment package for the care environment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Immunodeficiency Virus (HIV) Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

A full factorial randomized controlled trial using Multiphase Optimization STrategy (MOST) with 4 component interventions, each at 2 levels (off/on), for a total of 16 component conditions.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Condition 1

Participants will receive the Core Component.

Group Type NO_INTERVENTION

No interventions assigned to this group

Condition 2

Participants will receive the Core Component and Combination-NRT intervention.

Group Type EXPERIMENTAL

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 3

Participants will receive the Core Component and Text Messaging intervention.

Group Type EXPERIMENTAL

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Condition 4

Participants will receive the Core Component as well as the Combination-NRT and Text Messaging interventions.

Group Type EXPERIMENTAL

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 5

Participants will receive the Core Component and Peer Mentoring intervention.

Group Type EXPERIMENTAL

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Condition 6

Participants will receive the Core Component as well as the Combination-NRT and Peer Mentoring interventions.

Group Type EXPERIMENTAL

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 7

Participants will receive the Core Component as well as the Text Messaging and Peer Mentoring interventions.

Group Type EXPERIMENTAL

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Condition 8

Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Peer Mentoring interventions.

Group Type EXPERIMENTAL

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 9

Participants will receive the Core Component and Motivational Interviewing Counseling intervention.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Condition 10

Participants will receive the Core Component as well as the Combination-NRT and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 11

Participants will receive the Core Component as well as the Text Messaging and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Condition 12

Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 13

Participants will receive the Core Component as well as the Peer Mentoring and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Condition 14

Participants will receive the Core Component as well as the Combination-NRT, Peer Mentoring and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Condition 15

Participants will receive the Core Component as well as the Text Messaging, Peer Mentoring and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Condition 16

Participants will receive the Core Component as well as the Combination-NRT, Text Messaging, Peer Mentoring, and Motivational Interview Counseling interventions.

Group Type EXPERIMENTAL

Motivational Interviewing (MI) Counseling

Intervention Type BEHAVIORAL

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Peer Mentoring

Intervention Type BEHAVIORAL

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Skills-based Text Messaging

Intervention Type BEHAVIORAL

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Combination NRT

Intervention Type DRUG

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motivational Interviewing (MI) Counseling

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

Intervention Type BEHAVIORAL

Peer Mentoring

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

Intervention Type BEHAVIORAL

Skills-based Text Messaging

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

Intervention Type BEHAVIORAL

Combination NRT

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Status as HIV+
* Age 18 or older
* Currently smokes ≥ 5 CPD, on average, in past month
* Positive for salivary cotinine
* Able to understand the nature of the study and the consenting process
* Is engaged in HIV clinical care
* Living in larger NYC metropolitan area currently and for the next 6-8 months

Exclusion Criteria

* Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy
* Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)
* Currently participating in a smoking cessation program
* Pregnant or nursing and plans to be in next 6 months
* Has schizophrenia/schizo-affective disorder
* Does not have a functioning mobile phone that can receive text messages
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

New York University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York University School of Global Public Health

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jennifer Cantrell, DrPH, MPA

Role: CONTACT

212-998-5797

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jennifer Cantrell, DrPH, MPA

Role: primary

212-998-5797

Rachel Warshaw, MPH

Role: backup

212-992-3948 ext. 23948

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CA268932

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Learn to Quit-HIV Pilot Study
NCT04609514 COMPLETED NA
E-cigarette Harm Reduction Among PLWHA in South Africa
NCT06169813 ACTIVE_NOT_RECRUITING PHASE1